SageView Advisory Group LLC Has $1.10 Million Stock Holdings in CME Group Inc. $CME

Key Points

• SageView Advisory Group LLC has reduced its stake in CME Group Inc. by 20.0%, resulting in holdings worth approximately $1.10 million following the sale of 1,031 shares during the first quarter.
• Citigroup and Oppenheimer have recently upgraded their price targets for CME Group, with Citigroup setting it at $275.00 and Oppenheimer at $303.00, while the company has a consensus rating of "Hold".
• CME Group announced a quarterly dividend of $1.25 per share, which is part of an annualized dividend of $5.00, representing a yield of 1.9%.

SageView Advisory Group LLC decreased its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 20.0% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,135 shares of the financial services provider's stock after selling 1,031 shares during the quarter. SageView Advisory Group LLC's holdings in CME Group were worth $1,097,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Wayfinding Financial LLC acquired a new position in shares of CME Group during the 1st quarter worth approximately $25,000. Cornerstone Planning Group LLC increased its position in shares of CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after purchasing an additional 55 shares during the last quarter. Golden State Wealth Management LLC increased its position in shares of CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after purchasing an additional 98 shares during the last quarter. Alpine Bank Wealth Management acquired a new position in shares of CME Group during the 1st quarter worth approximately $32,000. Finally, Financial Gravity Asset Management Inc. acquired a new position in shares of CME Group during the 1st quarter worth approximately $32,000. Institutional investors and hedge funds own 87.75% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Citigroup boosted their price target on CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a research report on Thursday, July 3rd. Oppenheimer lifted their target price on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research note on Thursday, July 24th. Piper Sandler increased their price target on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. Wall Street Zen cut CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Finally, UBS Group dropped their price target on CME Group from $305.00 to $285.00 and set a "neutral" rating on the stock in a research note on Monday. Four analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, CME Group presently has a consensus rating of "Hold" and an average target price of $260.60.

Insiders Place Their Bets

In other CME Group news, insider Sunil Cutinho sold 11,896 shares of the company's stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the transaction, the insider directly owned 17,440 shares of the company's stock, valued at $4,734,436.80. This represents a 40.55% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director William R. Shepard bought 256 shares of CME Group stock in a transaction dated Wednesday, June 25th. The shares were bought at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the completion of the acquisition, the director owned 258,196 shares in the company, valued at $69,849,763.88. This represents a 0.10% increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 0.30% of the company's stock.

CME Group Stock Performance

Shares of NASDAQ CME opened at $259.91 on Thursday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The stock's fifty day moving average price is $274.10 and its two-hundred day moving average price is $270.11. CME Group Inc. has a one year low of $212.38 and a one year high of $290.79. The firm has a market cap of $93.67 billion, a price-to-earnings ratio of 25.16, a P/E/G ratio of 4.73 and a beta of 0.43.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the firm posted $2.56 EPS. The company's revenue for the quarter was up 10.4% on a year-over-year basis. On average, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's dividend payout ratio is currently 48.40%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.